In the present work, we have discovered that the activity of various MEK inhibitors against uveal melanoma cells in vitro and in vivo is significantly enhanced by concomitant inhibition of either RAC, PAK or IMPDH proteins. This evidence concerns the gene MAP2K7 and uveal melanoma.